Like Enbrel, MTX also efficiently reduced the progression and severity of arthritis, presumably by reducing the levels of pro-inflammatory mediators such as IL-1, IL-6, TNF and prostaglandins [66–69]. Here, IL1B is linked to arthritic joint disease.